跳至主要内容
临床试验/NL-OMON28697
NL-OMON28697已完成不适用

A FIXED-SEQUENCE CROSSOVER, DRUG-DRUG INTERACTION STUDY IN HEALTHY SUBJECTS

Denali Therapeutics, Inc0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
16

研究概览

简要总结

o

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects enrolled in the study were required to meet all the following criteria for study entry:
  • Men or women of any race, between 18 and 50 years of age, inclusive, at screening
  • BMI between 18.0 and 31.0 kg/m2, inclusive, and a body weight of at least 50.0 kg at Screening
  • In good health determined by no clinically significant findings from medical history, physical examination, and vital sign measurements
  • All clinical laboratory tests must be within normal limits or no clinically significant abnormalities

排除标准

  • Subjects who met any of the following criteria were excluded from study entry:
  • History of clinically significant hematological, renal, pancreatic, gastrointestinal, hepatic, cardiovascular, metabolic, endocrine, immunological, allergic disease, or other major disorders as determined by the investigator
  • Abnormal vital signs at screening
  • Clinically significant neurologic disorder
  • Evidence of ANY hepatic impairment
  • Clinically significant ECG abnormality at screening
  • History of clinically significant congestive heart failure.

研究者

相似试验

Drug-Drug interaction study in HV | 临床试验